Company Quick10K Filing
AVX
10-Q 2019-12-31 Filed 2020-02-05
10-Q 2019-09-30 Filed 2019-11-06
10-Q 2019-06-30 Filed 2019-08-06
10-K 2019-03-31 Filed 2019-05-17
10-Q 2018-12-31 Filed 2019-02-07
10-Q 2018-09-30 Filed 2018-11-06
10-Q 2018-06-30 Filed 2018-08-06
10-K 2018-03-31 Filed 2018-05-18
10-Q 2017-12-31 Filed 2018-02-08
10-Q 2017-09-30 Filed 2017-11-03
10-Q 2017-06-30 Filed 2017-08-07
10-K 2017-03-31 Filed 2017-05-19
10-Q 2016-12-31 Filed 2017-02-09
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-08-04
10-K 2016-03-31 Filed 2016-05-20
10-Q 2015-12-31 Filed 2016-02-05
10-Q 2015-09-30 Filed 2015-11-04
10-Q 2015-06-30 Filed 2015-08-05
10-K 2015-03-31 Filed 2015-05-20
10-Q 2014-12-31 Filed 2015-02-05
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-06
10-K 2014-03-31 Filed 2014-05-21
10-Q 2013-12-31 Filed 2014-02-07
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-05
10-K 2013-03-31 Filed 2013-05-22
10-Q 2012-12-31 Filed 2013-02-07
10-Q 2012-09-30 Filed 2012-11-07
10-Q 2012-06-30 Filed 2012-08-09
10-K 2012-03-31 Filed 2012-05-24
10-Q 2011-12-31 Filed 2012-02-08
10-Q 2011-09-30 Filed 2011-11-08
10-Q 2011-06-30 Filed 2011-08-08
10-K 2011-03-31 Filed 2011-05-20
10-Q 2010-12-31 Filed 2011-02-08
10-Q 2010-09-30 Filed 2010-11-04
10-Q 2010-06-30 Filed 2010-08-06
10-K 2010-03-31 Filed 2010-05-20
10-Q 2009-12-31 Filed 2010-02-05
8-K 2020-03-30
8-K 2020-03-12
8-K 2020-02-21
8-K 2020-02-21
8-K 2020-01-23
8-K 2019-11-27
8-K 2019-10-28
8-K 2019-07-26
8-K 2019-07-24
8-K 2019-04-22
8-K 2019-02-06
8-K 2019-01-28
8-K 2019-01-24
8-K 2019-01-08
8-K 2018-12-20
8-K 2018-10-24
8-K 2018-10-17
8-K 2018-07-25
8-K 2018-07-18
8-K 2018-05-24
8-K 2018-05-01
8-K 2018-04-30
8-K 2018-04-25
8-K 2018-03-30
8-K 2018-02-07
8-K 2018-01-31
8-K 2017-12-31
8-K 2017-12-29

AVX Financials

AVX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
Supernova Partners Acquisition Co III, Ltd. (STRE-WT)
30DC (TDCH)
Ameri Metro, Inc. (formerly Yellowwood) (ARMT)
Gores Technology Partners, Inc. (GTPAW)
Bioquest Corp (BQST)
BriaCell Therapeutics Corp. (BCTXW)
3D Total Solutions (DTLS)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash329278437395422482577482474463461333312331382322366426454483511481579634619464547458488354401330425
Accounts Receivable252221189206201203177200210186206203200181187171166152162163167175177183190241275269262250257243236
Inventory542561579566541544557542566575551543523536536531507490484484472463474473465497517514556591632666680
PP&E1,4931,4641,4121,4501,4111,4351,4241,6301,6551,6301,6371,6371,5781,5411,4682012052101,5132252262241,5292552683751,9804254384431,982478489
Assets2,3962,3822,3902,4682,5582,5752,5802,5912,6372,4902,3852,4112,4122,4022,4592,3432,3662,3542,4102,4222,4362,4472,4772,5162,5502,5852,6732,6902,7412,7702,8132,8492,848
Accounts Payable483838443541414861615052523835353130424235364446476990979391958883
Long-Term Debt
Liabilities291244246347606599593604625471337343343319327188200211233236238258261263265405429450441433429421425
Stockholders' Equity2,1052,1382,1442,1211,9521,9761,9871,9882,0122,0192,0482,0682,0692,0832,1322,1552,1662,1432,1772,1862,1982,1902,2162,2532,2852,1802,2432,2412,3002,3372,3842,4272,422
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue436405341363353373340369405346351351370322316301304287304315327341330331353432330454456442439402377
Cost of Revenue312294263285284314277301328278280265278243239223233221230245266261256258275350361346330316317301298
Gross Profit12511178786969626877687185105797777726674706279747477828610812612612210180
R&D
SG&A312928283031292930322830282830292831323129282931353740404142454242
Tax282014-34-881315121365162614-531511-61110917131314141201517161398
Net Income686237-14-1372820283731394154391023628533302736343135-9334567274695533
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating353353276728543837-86-5978523433-31805364663956356465359841363227
Cash Investing-76-70122-55-244856-27-309474-187-54-239-8-1728-17-1810-71767-6488-162529-8289
Cash Financing-10-12-15-15-15-16-14-15-16-18-17-18-18-13-20-21-20-21-19-18-20-13-14-17-17-39-23-16-19-21-20